Aspigola 8,75 mg po dozi, sprej za usnu sluznicu, otopina
| Name | Aspigola 8,75 mg po dozi, sprej za usnu sluznicu, otopina |
|---|---|
| Former Name | Flurbiprofen Bayer 8,75 mg po dozi, sprej za usnu sluznicu, otopina |
| Marketing Authorisation Number | HR-H-109653856 |
| Active Substance | flurbiprofen |
| Composition | jedna doza (3 potiska) sadržava 8,75 mg flurbiprofena jedan potisak sadržava 2,91 mg flurbiprofena jedan ml otopine u spreju za usnu sluznicu sadržava 17,16 mg flurbiprofena |
| Pharmaceutical Form | Sprej za usnu sluznicu, otopina |
| Manufacturer | Laboratorium Sanitatis S.L., Miñano, Alava, Španjolska Industria Quimica Y Farmaceutica Vir S.A., Alcorcon, Madrid, Španjolska |
| Marketing Authorisation Holder | Bayer d.o.o., Radnička cesta 80, Zagreb, Hrvatska |
| Marketing Authorisation Date | 24.11.2022 |
| MA Period of Validity | 24.11.2027 |
| Classification Number | UP/I-530-09/21-01/129 |
| Registration Number | 381-12-01/70-22-09 |
| Prescription | Medicinal product not subject to medical prescription |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | allowed |
| ATC Code | R02AX01 |
| Marketing status | Marketed |
| Shortage status | No shortage |
| SmPC | download |
| PL | download |
| Summary of risk management plan | download |